应用血管紧张素转换酶抑制剂与β1受体阻滞剂联合治疗慢性充血性心力衰竭26例
出处
《中国实用医药》
2008年第18期141-142,共2页
China Practical Medicine
二级参考文献22
-
1Cleland J,Semple P, Hodsman P. Angiotensin levels, hemodynamics and sympathoadrenal function after low-dose captopril in heart failure[ J ]. Am J Med,1984,77(5) :880-886.
-
2Rocca HP,Weilenmann D, Kiowski W. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormonal levels in patients with chronic heart failure[J]. Am Heart J,1999,138(4 pt 1 ) :654-662.
-
3Pacher R, Glibits S, Bergler J. Clinical sad neurohumoral response of patients with severe congestive heart failure treated with two different captopril desages[J]. Eur Heart J, 1993,14(2) :273-278.
-
4Pellenc PM, Rudnicki A, Leclereq P. Enaiapril in the treatment of mild to moderate heart failure in general medical practive:a prospective and multicenters study concerning 17 546 patients[ J ]. Acta Cardiol, 1995,50 ( 3 ) ; 187 -201.
-
5Quinapril Research Group. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure[J]. Eur Hem J,1991,12(6) :705-711.
-
6Testa M, Yeh g, Lee P. Cireulating levels of cytokines and the endogenous modulators in patients with mild to severe congestive heart failure due to coroanry artery disease or hypertension[J]. J Am Coll Cardiol,1996,28(4) :964-971.
-
7Gullestad L, Aukrust P, Ueland T. Effects of hish-versus low-dose angiotensin converting enzyme inhibitor on cytokine levels in chronic heart failure [ J ]. J Am Coll Cardiol,1999,34(7) :2061-2067.
-
8Denis L,CLEMENT.Tomas M. Long-term effects of clinical outcome with low and high dose in the captopril in heart insufficient patients study[J]. Acts Cardiol.2000,55(1) :1-7.
-
9Pacher M ,Poole-Wilson PA ,Armstrong PW. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor,lisinopril,on mortality in chronic heart failure[J]. Ciroulation,1999,100(23) :2312-2318.
-
10The Network Investigators. Clinical outcome with enalapril in symptomatic chrohic heart failure;a dose comparison[J]. Eur Heart J,1995,19(3) :481-489.
共引文献12
-
1林郁生,林洁英,翁立坚,仇烨,吴伟森,潘英.不同剂量卡托普利治疗小儿慢性充血性心力衰竭临床研究[J].山东医药,2004,44(25):19-20. 被引量：3
-
2王成,谢振武,刘利群,王秀英,许毅,李雯,郑慧芬.氢氯噻嗪、依那普利、美托洛尔、螺内酯联合治疗扩张型心肌病疗效评估[J].实用儿科临床杂志,2005,20(10):992-994. 被引量：5
-
3孙瑞雪.慢性充血性心力衰竭62例治疗体会[J].基层医学论坛,2008,12(20):614-615.
-
4杨爽.川芎嗪联合卡托普利治疗慢性充血性心力衰竭的临床观察[J].实用心脑肺血管病杂志,2009,17(1):45-46. 被引量：5
-
5苏毅,慕春言,赵倡武.贝那普利对慢性心力衰竭患者临床及血浆脑钠素水平的影响[J].中国现代药物应用,2009,3(19):12-13.
-
6潘纪栓.福辛普利联合美托洛尔治疗慢性心力衰竭46例疗效观察[J].河南职工医学院学报,2010,22(1):23-24. 被引量：2
-
7彭波涛.美托洛尔联合依那普利治疗慢性充血性心力衰竭42例疗效观察[J].中国临床实用医学,2010,4(4):153-154. 被引量：5
-
8廖春梅.卡托普利治疗小儿心力衰竭临床疗效观察[J].中国现代药物应用,2010,4(12):146-147. 被引量：2
-
9谢锦群.慢性心力衰竭的药物治疗[J].社区卫生保健,2010,9(5):347-348. 被引量：3
-
10赵超英.美托洛尔治疗慢性心力衰竭88例临床观察[J].中国医药指南,2011,9(36):106-107.
-
1胡雅光.比索洛尔对慢性心力衰竭心率的影响[J].医师进修杂志,2004,27(1):44-44. 被引量：1
-
2傅秀珍,程海滨,王玉香,索晓霞.美托洛尔治疗不稳定心绞痛268例疗效观察[J].滨州医学院学报,1997,20(5):471-471.
-
3胡光,赵长龙.比索洛尔与美托洛尔治疗高血压病的对比研究[J].河北医学,1998,4(3):13-15. 被引量：1
-
4王守君,杨杰,裴立凯,翟萍.倍他乐克和卡托普利联用治疗充血性心力衰竭疗效分析[J].中国厂矿医学,2003,16(2):110-111. 被引量：1
-
5杨树森,孟繁超,徐炳柱,张颖,杨宝仁.β_1受体阻滞剂美托洛尔治疗心力衰竭的临床观察[J].哈尔滨医科大学学报,1995,29(3):253-254.
-
6周浩.美托洛尔对扩张性心肌病伴血压增高患者心功能及预后的影响[J].中外女性健康研究,2015,0(2):67-68.
-
7徐丽华.慢阻肺合并冠心病35例临床分析[J].医药论坛杂志,2007,28(8):84-84.
-
8唐中文,武宗寅.β1受体阻滞剂用于COPD并发冠心病患者治疗的临床观察[J].世界最新医学信息文摘,2016,16(12):5-6.
-
9张双平,张唐山,马一琼.卡维地洛治疗中老年高血压伴充血性心力衰竭临床观察[J].中国药物与临床,2009,9(B07):40-42. 被引量：2
-
10王金泉,徐英勇,王燕,王艳鹏,贺林.β_1受体阻滞剂在慢性阻塞性肺疾病合并慢性心力衰竭的应用研究[J].中国伤残医学,2013,21(12):33-34. 被引量：7
